quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:10:00·15d
PRRelease
Assertio Holdings Inc. logo
Hamilton Lane Incorporated logo

Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio

ASRT· Assertio Holdings Inc.HLNE· Hamilton Lane Incorporated
Health CareFinance
Original source

Companies

  • ASRT
    Assertio Holdings Inc.
    Health Care
  • HLNE
    Hamilton Lane Incorporated
    Finance

Recent analyst ratings

  • Apr 16HLNEUpdateAnalyst$166.00
  • Apr 9ASRTUpdateH.C. Wainwright$18.00
  • Dec 11HLNEUpdateUBS$166.00
  • Nov 6HLNEUpdateGoldman$165.00
  • Oct 14HLNEUpdateOppenheimer$181.00
  • Oct 13HLNEUpdateKeefe Bruyette$150.00

Related

  • PR1d
    Hamilton Lane Incorporated to Announce Fourth Fiscal Quarter and Full Fiscal Year 2026 Results on May 21, 2026
  • PR2d
    Hamilton Lane Launches Two Interval Funds Across Private Credit and Private Infrastructure, Leveraging Extensive Expertise and Deep Track Records
  • SEC2d
    SEC Form SC14D9C filed by Assertio Holdings Inc.
  • SEC2d
    Assertio Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR2d
    Assertio Provides Update on Garda Therapeutics Tender Process
  • PR4d
    Hamilton Lane Announces Senior Promotions and Appointments
  • ANALYST8d
    Hamilton Lane upgraded by Analyst with a new price target
  • SEC9d
    SEC Form SC14D9C filed by Assertio Holdings Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022